secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001193125-25-280167
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Q3 revenue $16k, net loss $7.8M; launches Medicaid pilot in Nevada
-----------------------------------------------------------------------

- Revenue $16k vs $29k YoY; net loss $7.8M vs $7.9M; cash $102.4M funds operations through 2028.
- Inaugural Medicaid pilot launched in Nevada; payer discussions across 13 states covering 33% of U.S. births.
- PRIME study full results on track for publication in 2025; health economic data also forthcoming.
- Appointed Dr. Tiffany Inglis as CMO and Marisol Urbano as Head of Commercial Operations.
- SG&A rose to $5.7M from $5.4M due to commercial investments; R&D fell to $3.3M as PRIME study concluded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000119312525280167/0001193125-25-280167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000119312525280167/sera-20251113.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-280167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer